Daptomycin

Description

1. Product Overview

Daptomycin is a high-potency cyclic lipopeptide antibiotic recognized for its exceptional efficacy against Gram-positive bacterial strains, including multidrug-resistant pathogens. Primarily utilized in pharmaceutical manufacturing, it serves as a critical active pharmaceutical ingredient (API) in the production of injectable and intravenous therapeutic formulations. Strategically, Daptomycin provides manufacturers with a reliable solution to meet stringent regulatory standards while addressing the global demand for advanced antimicrobial therapies. Its superior stability, bioactivity, and consistent quality make it a cornerstone ingredient for companies targeting high-value hospital and clinical applications. For industrial buyers, securing a dependable supply of Daptomycin is a competitive differentiator in both domestic and international pharmaceutical markets.

2. Key Specifications & Technical Characteristics

• Chemical Composition: Cyclic lipopeptide antibiotic
• Purity / Grade: ≥ 98% (Pharmaceutical/Bulk API grade)
• Physical Characteristics: White to off-white powder; hygroscopic; soluble in aqueous solutions under specified conditions
• Particle Size: Fine powder, optimized for uniform dissolution
• Density: Approximately 1.0 g/cm³ (bulk)
• Packaging Options: 25 kg fiber drums with inner polyethylene liner; customizable packaging available for export compliance
• Shelf Life: 24 months under recommended storage (cool, dry, dark conditions)
• Storage Conditions: 2–8°C preferred; protect from moisture and light

3. Core Industrial Applications

• Primary Industries: Pharmaceutical API manufacturing, clinical-grade injectable production, biotechnology research
• Operational Use Cases:
  • Production of sterile injectable formulations for systemic bacterial infections
  • Integration into combination therapies for resistant infections
  • R&D applications in antimicrobial drug development
• Performance Advantages:
  • High potency ensures lower dosing requirements compared to alternatives
  • Excellent stability reduces degradation during formulation and storage
  • Consistent bioactivity supports regulatory compliance and reliable batch-to-batch performance
  • Optimized particle characteristics enable efficient mixing and processing in industrial production

4. Competitive Advantages

• Quality Consistency: Stringent QC and batch testing for uniform purity and activity
• Supply Reliability: Secured production capacity ensures uninterrupted industrial supply
• Logistics Capability: Global shipping experience with temperature-controlled transport options
• Price Competitiveness: Strategic sourcing reduces overall procurement costs
• Sustainability & Environmental: Compliant manufacturing processes with minimized chemical waste
• Technical Support: Full documentation including certificates of analysis (CoA), material safety data sheets (MSDS), and regulatory compliance reports

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): Bulk 20 MT
• Loading Capacity per Container: 20 MT per 20-foot container, temperature-controlled options available for sensitive shipments

Daptomycin is positioned as a strategic API investment for industrial-scale pharmaceutical producers seeking superior quality, reliability, and regulatory-aligned sourcing.